Synchron: AUD$1.5M NHMRC Awards Grant to Expand Feasibility Trials for Stentrode, the First Interventional Neuromodulation Platform

Press/Media

Period25 Jun 2020

Media coverage

1

Media coverage

  • TitleSynchron: AUD$1.5M NHMRC Awards Grant to Expand Feasibility Trials for Stentrode, the First Interventional Neuromodulation Platform
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date25/06/20
    PersonsThomas Oxley